Securities firms' burden on biopharma companies' IPO

Retrieved on: 2020-12-02 07:41:15

Tags for this article:

Click the tags to see associated articles and topics

Securities firms' burden on biopharma companies' IPO. View article details on hiswai:

Excerpt

Market interests and profitability of <b>biopharma</b> companies have ... 21 newly listed firms out of 65 IPO cases are <b>biopharmaceutical</b> companies, drawing ...

Article found on: www.koreatimes.co.kr

View Original Article